Nifty faces a reality check as earnings estimates are slashed. Axis Securities flags 6 high-conviction stocks like ICICI Bank and…
Over 270 companies, including L&T, M&M, Swiggy, and Paytm, will announce earnings and possible dividends this week. Stay updated on…
Lupin settles US antitrust lawsuits for $30 million with Humana, denies wrongdoing, and aims to avoid prolonged legal costs and…
The Indian Pharmaceutical Market (IPM) grew 10.1% year-on-year in March 2026, according to the report. Pricing contributed 5.5% to growth,…
A sharp sell-off gripped markets as pharma stocks plunged on US tariff fears and rising crude prices dragged key sectors,…
Nomura has a ‘Buy’ rating on Zydus Lifesciences, with the stock at Rs 891 and a target price of Rs…
A key US drug approval is putting this pharma stock back on the radar, with a global brokerage pointing to…
Semaglutide prices in India are set to drop sharply as generics enter the market after patent expiry, improving affordability for…
Lupin and Zydus partner to co-market semaglutide in India, entering a Rs 1,200 crore market with over 20 competitors and…
Biocon earns USFDA nod for Liraglutide injection, boosting its diabetes drug portfolio. Explore investment opportunities now!
While Nifty Pharma giants struggle with regulatory headwinds and pricing pressures, two outliers are quietly catching the attention of smart…
Stay updated on key stock moves as firms announce dividends, stake sales, fund-raising, and contracts—check today’s top market movers now!
Track top stocks like PowerGrid, IRFC, RVNL, and Waaree Energies after key approvals, project wins, and stake sales—see which ones…
L&T secures a Rs 1,000–Rs 2,500 crore order from GOI’s Department of Atomic Energy to establish the LIGO project in…
IBM’s stock took a hit after Anthropic, the company behind the AI model Claude, said its new tool can make…
Track key stocks in focus today with major updates, investments, and orders—review top picks to stay ahead in the market!
Discover 10 top stocks with up to 60% upside as leading brokerages issue fresh Buy calls—explore these high-potential opportunities now!
Motilal Oswal raises the price target for Tata Steel and maintains ‘Buy,’ forecasting a 15% upside—discover 5 reasons driving their…